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Abstract 
Background 
Socioeconomic deprivation (SED) is associated with shorter survival across a range of cardiovascular 
and non-cardiovascular diseases.  The association of SED with survival after heart transplantation in 
England, where there is universal healthcare provision, is unknown. 
Methods and results 
Long-term follow-up data were obtained for all patients in England who underwent heart 
transplantation between 1995-2014.  We used the United Kingdom Index of Multiple Deprivation (UK 
IMD), a neighbourhood level measure of SED, to estimate the relative degree of deprivation for each 
recipient.  Cox proportional hazard models were used to examine the association between SED and 
overall survival and conditional survival (dependant on survival at one year after transplantation) 
during follow-up.  Models were stratified by transplant center and adjusted for donor and recipient age 
and sex, ethnicity, serum creatinine, diabetes and heart failure aetiology. 2384 patients underwent heart 
transplantation.  There were 1,101 deaths during 17,040 patient years follow-up. Median overall 
survival was 12.6 years and conditional survival was 15.6 years.  Comparing the most deprived versus 
the least deprived quintile, adjusted hazard ratios for all-cause mortality were 1.27 (1.04-1.55, 
p=0.021) and 1.59 (1.22-2.09, p=0.001) in the overall and conditional models, respectively.  Median 
overall and conditional survival was 3.4 years shorter in the most deprived quintile compared with the 
least deprived.  
Conclusions 
Higher SED is associated with shorter survival in heart transplant recipients in England and should be 
considered when comparing outcomes between centres.  Future research should seek to identify 
modifiable mediators of this association. 
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Introduction 
Patients with advanced heart failure have a poor prognosis and quality of life.  Heart transplantation 
remains the definitive treatment for advanced heart failure that is refractory to conventional medical 
and surgical therapy.  Heart transplantation offers improved survival
1
 and quality of life
2
.  Over 
110,000 heart transplants have been performed worldwide and recorded in the Registry of the 
International Society for Heart and Lung Transplantation.  Survival is excellent with a median survival 
from transplantation of 11 years, and 13 years for patients that survive the first year
3
.  
Socioeconomic deprivation (SED) refers to the social and economic conditions in which an individual 
or group of individuals live.  Determinants of SED include wealth and income, education, employment 
and occupation, access to services and local environmental factors such as crime
4
.  SED has been 
associated with increased incidence, earlier presentation and shorter survival in a range of 
cardiovascular diseases
5
, including heart failure
6
. Socioeconomic gradients in outcomes after heart 
transplantation have been described in the United States (US).  Greater SED was associated with an 
increased risk of graft failure and an increased risk of acute rejection in adult
7
 and paediatric 
recipients
8, 9
.  In addition, health insurance status was associated with survival after heart 
transplantation in the US.  Recipients with Medicaid or Medicare insurance had shorter post-transplant 
survival than recipients with private insurance
10
. 
The National Health Service (NHS) in England provides universal healthcare to all residents, free at 
the point of delivery.  There is a small charge for prescribed medications (a set fee, not dependent on 
the drug dispensed), but some patients with long-term conditions or those living in low-income 
households are exempt from these charges.  Universal health care systems such as the NHS are thought 
to reduce socio-economic inequalities in health
11
. There are socioeconomic gradients in the incidence, 
prevalence and case-fatality rates of heart failure in England, but the magnitude of these gradients has 
reduced in the last decade
12
. Importantly, use of evidence-based treatments for heart failure appear to 
 4 
be independent of SED within the NHS in England.  The association between SED and outcomes after 
heart transplantation has not been examined in a country with a universal healthcare system.  We have 
used data from the United Kingdom (UK) Transplant Registry to examine the association between 
SED and survival after heart transplantation in England.  
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Methods 
Study population 
The UK Transplant Registry, maintained by NHS Blood and Transplant, was established in April 1995 
to monitor overall and center-specific outcomes.  Heart transplantation was performed in seven 
specialist centers in England in 1995 and five centers remain active in 2014.  Any patient entitled to 
NHS treatment may be referred for transplant assessment, irrespective of gender, socio-economic 
status or ethnicity.  All centers apply national consensus guidelines to select patients for heart 
transplantation
13
.  Patients requiring continuous inotropic support or temporary mechanical circulatory 
support are given priority in organ allocation (equivalent to UNOS Status I).  Patients are placed on a 
national waiting list. Organs are allocated to patients on the urgent list nationally according to blood 
group and waiting time. For the last financial year, 80% of patients receiving a transplant were on the 
urgent list.  Non-urgent listed patients are offered a heart if no suitable patient is found on the urgent 
list and centers have some latitude in allocating these donor hearts.   Post-transplant care is not 
standardised between transplant centers.  Each center collects individual patient data at the time of 
listing, at the time of transplantation and at regular intervals until death.  Data are monitored and 
subjected to periodic external validation.  We included all patients aged 18 years and above who 
received a heart transplant from 1995-2014 and were resident in England at the time of transplant. This 
study was approved by an institutional review committee. Prior to April 2010, the UK Transplant 
Registry data was collected for audit purposes with presumed consent. Since April 2010, all patients 
have provided written consent. 
Socioeconomic deprivation 
The UK index of multiple deprivation (IMD) was used to measure SED.  The UK IMD is a local area 
based model with seven domains; (1) Income, (2) Employment, (3) Health and disability, (4) 
Education, skills and training, (5) Barriers to housing and services, (6) Living environment and (7) 
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Crime.  Each domain is assessed for 32,482 Lower Layer Super Output areas (LSOAs) in England 
(each of which has approximately 1,000-1,500 residents) and used to rank the relative deprivation of 
LSOAs.  We obtained the IMD rank for each patient using their postcode at the time of transplantation 
and the 2010 UK IMD dataset
14
.  Patients were categorized into five quintiles of deprivation based on 
the rank of the LSOA in which they lived at the time of transplantation, with group 1 being most 
deprived and group 5 least deprived. 
Outcomes 
The primary outcome measure was time to all-cause mortality during follow-up (overall survival).  
Secondary outcome measures were 30-day post-transplant mortality, one-year post-transplant 
mortality and time to all-cause mortality during long-term follow up in those who survived the first 
year post-transplant (conditional survival).  Graft outcome was recorded as ‘graft failure’, ‘death with 
functioning graft’ or ‘death only recorded’.  
Statistical analysis 
Categorical variables were summarised as counts and percentages. Continuous variables were 
summarised as either median [interquartile range] or mean (standard deviation) as deemed appropriate 
after graphical examination of their distribution. Baseline characteristics were assessed for a trend 
across quintiles of SED using logistic, ordinal or linear regression as appropriate. These regression 
models were adjusted for transplant centre. 
The association of SED with 30-day post transplant mortality was assessed using logistic regression. 
The model was adjusted for age, sex, ethnicity (white/non-white), diabetes, heart disease aetiology 
(dilated cardiomyopathy, ischaemic heart disease, congenital heart disease, other), pre-transplant 
serum creatinine, previous cardiac surgery, inpatient or outpatient prior to transplantation, ventilation 
status at registration (ventilated/not ventilated), donor age, donor sex and transplant center. One year 
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post-transplant mortality was assessed using a multivariable adjusted Cox proportional hazards model 
stratified by transplant center adjusted for the same variables as the model for 30-day mortality. 
Overall survival and conditional survival was assessed using multivariable adjusted Cox Proportional 
Hazards models stratified by transplant center. These models were adjusted for age, sex, recipient 
ethnicity, heart disease aetiology (as above), recipient diabetes, pre-transplant serum creatinine, donor 
sex and donor age.  For Cox PH models, individuals alive at last follow up were censored at that time. 
Patients who died on the day of transplant (n=23) were assigned a follow up duration of 0.001 years 
for inclusion in Cox models. 
IMD rank was modelled as a categorical variable grouped in quintiles, using the least deprived quintile 
as the reference group, as well as continuously after verified absence of non-linear associations.  The 
proportional hazard assumption was satisfied for overall and conditional survival models.  Survival 
curves were generated using Kaplan Meier method by SED quintiles and compared using the log-rank 
test.  Estimates of median survival times by quintiles of SED and differences thereof were also 
presented as additional summary statistics.   
In order to assess the association of SED with graft failure and death with a functioning graft 
independently, we modelled IMD rank as a continuous variable in a multivariable adjusted competing 
risk regression model treating the other outcome as a competing risk.  Endpoints were recorded as 
graft failure or death with a functioning graft in all patients included in the conditional model 
compared with 38.6% in the overall model because the majority of events recorded as ‘death only 
recorded’ occurred in the first year post-transplant.  For this reason, the competing risk regression 
analysis was performed only for conditional survival. 
The association between SED and overall and conditional survival was examined for four subgroups 
by adding an interaction term to the adjusted Cox PH models. Subgroups included recipient age, sex, 
heart failure aetiology (ischaemic/non-ischaemic) and ethnicity (white/non-white). 
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For categorical variables with missing data, an indicator variable was assigned for missing data points 
to allow inclusion of patients with missing data points in the multivariable adjusted models.  For 
creatinine, the only continuous variable with missing data, the 260 (10.9%) missing data points were 
imputed as the mean value across the cohort.  
A two sided p-value <0.05 was considered significant throughout.  All analysis was performed in 
STATA (version 14; StataCorp, USA).
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Results  
A total of 2961 heart transplants were performed in the UK between 1995-2014.  We included 2391 
patients who were resident in England at the time of transplantation.  We excluded 7 patients that did 
not have outcome data recorded and 2384 patients remained as the cohort analysed in this study.  The 
characteristics of the cohort overall and by SED quintile are shown in Table 1.  Median [IQR] 
recipient age was 51 [41-57] years and 79% were male.  Recipients in the more deprived quintiles 
were slightly younger, more likely to be black or South Asian and had a lower serum creatinine. 
30-day mortality 
30-day mortality was 11.4% (272 deaths) for the cohort as a whole and was 9.4%, 12.3%, 11.1%, 
13.1% and 11.3% for quintile 1 (most deprived) to quintile 5 (least deprived) of SED respectively.  
There was no significant difference in 30-day mortality between SED quintiles (Table 2).   
One-year survival 
Kaplan Meier predicted one-year survival was 80.6 (95% CI 78.9-82.1)% for the cohort as a whole. 
SED was not associated with any difference in one-year survival (Table 3). 
Long-term survival 
The median (IQR) duration of follow up was 6.13 (1.00-12.1) years.  There were 1101 deaths during 
17,040 patient years at risk.  Median (95% CI) overall survival was 12.6 (11.9-13.5) years and 
conditional survival was 15.6 (14.9-16.4) years.   
A higher level of SED was associated with a higher risk of death in the long-term (Table 4).  Median 
overall and conditional survival was 3.4 years shorter in the most deprived compared with the least 
deprived quintile (Table 4).  Survival curves for the most deprived and least deprived quintiles are 
shown in Figure 1.  The association between deprivation in each of the seven IMD domains and 
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survival is shown in Table 5.  In competing risks regression models for conditional survival, hazard 
ratios per quintile increase in IMD rank (indicating greater SED) were similar for both graft failure 
(1.14 (1.05-1.24), p=0.001) and death with a functioning graft (1.10 (1.02-1.18), p=0.012).  There was 
no significant interaction between the association of SED and survival with sex, ethnicity or heart 
failure aetiology (Figure 2).  In the conditional survival model, there was a significant interaction with 
age such that the association between higher levels of SED and worse outcome was stronger in 
younger recipients. Hazard ratios were unchanged when using alternative approaches to stratification 
in Cox regression models to account for center effect, including adjusting for center as a covariate 
(fixed effect) or estimating a shared frailty variance by center (random effect). 
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Discussion 
We have demonstrated that a higher level of SED is associated with shorter survival after heart 
transplantation in patients in England.  Median overall and conditional survival was 3.4 years shorter 
for those who live in the most deprived compared with the least deprived areas.  However, there was 
no association between SED and either 30-day or 1-year mortality.  Our study is the first to 
demonstrate an association between SED and long-term survival after heart transplantation in a 
country with universal provision of healthcare.  These findings may be relevant to other countries that 
have a heart transplantation programme within a universal healthcare system. 
A number of studies have examined the association between SED and outcomes after heart 
transplantation in adults, most of which have been conducted in the US.  In a small study of 44 patients 
at a single center in Brazil from 2000-2005, no association was observed between SED and survival 
after heart transplantation
15
.  However, SED was not clearly defined and there was no attempt to 
separate the effect of SED from other risk factors for mortality.  A larger retrospective study of 520 
patients at four transplant centers in the US from 1996-2005 did not find an association between SED 
and survival to discharge, but those living in more deprived neighbourhoods had a greater incidence of 
acute rejection and allograft loss during long term follow-up
7
.  While all patients in their analysis had 
medical insurance, the type of insurance varied according to socioeconomic status.  Analysis of the 
United Network for Organ Sharing (UNOS) database from 1997-2008 showed shorter survival after 
heart transplantation in patients with Medicaid or Medicare insurance, who tend to have lower socio-
economic status, compared with patients with private medical insurance.
10
.  It has been suggested that 
Medicaid and Medicare co-payments for immunosuppressive medications might adversely affect 
compliance and lead to worse outcomes after heart transplantation.  
In contrast to the US, the NHS in England provides universal healthcare to all residents.  We have 
shown that SED has an adverse effect on post-transplant survival despite universal healthcare 
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provision, but the reasons for this finding are uncertain.  Uptake of healthcare services and engagement 
with healthcare providers may be lower in areas of greater SED
16
.  Language barriers may deter non-
English speaking ethnic minorities from accessing healthcare
17
.  Individuals under financial pressure 
may be unable to afford time off work to access healthcare or be unable to afford travel costs to distant 
heart transplant centers.  In Scotland, patients with heart failure who were more socioeconomically 
deprived were less likely to have regular contact with their general practitioner
18
 and delays in 
presentation with acute myocardial infarction have been observed more frequently in more deprived 
Medicare beneficiaries in the US
19
.  In addition, more deprived individuals have been reported to have 
higher rates of medication non-adherence
20
.  Our findings suggest that the association between SED 
and post-transplant adverse events in the US and UK is complex and not wholly explained by 
inequitable access to post-transplant healthcare and expensive immunosuppression.  It is likely that 
factors such as engagement with healthcare, compliance and health behaviours, all of which display 
socioeconomic gradients, may be important.  As such, our findings are relevant to transplant 
programmes across the world, regardless of the healthcare system. 
There are numerous other potential mediators of the association between greater SED and shorter 
survival after heart transplantation.  Shorter survival appears to be driven by a higher risk of both graft 
failure and death from other causes.  Cardiac allograft vasculopathy (CAV) is present in over 50% of 
recipients at ten years after transplantation and is an important cause of allograft failure and death
21
.  
Conventional risk factors for atherosclerosis such as smoking, dyslipidaemia, diabetes and obesity all 
increase the risk of CAV
22, 23
, and are more prevalent in areas of socioeconomic deprivation
24, 25
.  
Abstinence from tobacco smoking is required before listing for heart transplantation in the UK.  
However, around 25% of heart transplant recipients were smoking during follow up when assessed by 
urinary cotinine screening, and these individuals had an increased risk of death from CAV and 
malignancy.
26
 Socioeconomic gradients in the prevalence of smoking were not assessed, but could 
mediate the effect of SED on survival if such gradients reflect those in wider society
24
.  
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Cytomegalovirus (CMV) seropositivity is more common in low-income households
27
, and has been 
associated with a greater risk of CAV
28
.  Malignancy is another important cause of death after heart 
transplantation and the incidence is 2.5 times greater than in the general population
29
.  There are 
socioeconomic inequalities in both the incidence
30
 and survival
31
 from a wide variety of cancers and 
these may apply equally to patients who have undergone heart transplantation.  
These findings should not deter clinicians from listing individuals from more deprived areas for 
transplantation.  Instead, strategies to reduce the disparity in outcomes should be explored.  Potential 
interventions include use of electronic dossette boxes to measure compliance, closer monitoring of 
immunosuppressive drug levels, education about post-transplant care, and support with lifestyle 
modifications such as smoking, diet, and exercise.  Use of the family or other social support networks 
may be beneficial
32
.  It is important to note that exposure to adverse socioeconomic conditions during 
childhood has been associated with poor cardiovascular health in later life
33
.  Some of the observed 
disparity in survival after heart transplantation may not be modifiable.  Nevertheless, heart transplant 
recipients have life-long follow up and there are numerous opportunities for intervention.  Socio-
demographic data for all recipients should be collected at both the individual and neighbourhood level 
to allow this subject to be studied further.  Such data would allow targeting and evaluation of the 
potential interventions described above.  This should be an area for future research in other types of 
solid organ transplant, where similar disparities in outcomes exist with SED
34-37
.   
The association between SED and post-transplant survival may be relevant for performance 
monitoring of heart transplant centres.  In the UK, risk adjustment models are used to allow continuous 
performance monitoring in each centre.  By stratifying our analyses by transplant centre and thus 
accounting for any differences in the baseline hazard for death between centers, we have demonstrated 
that the association between SED and survival is not a result of differences in care between centers.  
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Incorporation of SED into the risk adjustment used for performance monitoring should be evaluated to 
account for variation in the relative deprivation of patient cohorts at different centers. 
The strengths of our study are inclusion >99.5% of all heart transplant recipients in England over a 19-
year period with a median follow up time of over 6 years, use of a hard clinical endpoint (all-cause 
mortality) and use of a standardized measure (UK IMD) to assess SED.  There are several limitations 
of our study.  The UK Transplant Registry does not currently collect socioeconomic data at the 
individual level and while the IMD is an area based index that permits meaningful comparisons and 
monitoring of national, regional, and local socioeconomic gradients in health over time, it is only a 
proxy for individual-level socioeconomic data.  We included patients who underwent transplantation 
between 1995 and 2014, but used the 2010 IMD dataset for analysis.  It is possible that relative 
deprivation of an area could change, although most areas of the UK have remained in the same quintile 
of IMD scores over 25 years
38
.  We defined SED by post-code at the time of transplantation, but 
individuals may move during follow up.  Finally, there may be residual confounding from unmeasured 
variables such as HLA-matching and pre-transplant factors such as a history of smoking and 
hypertension.  
In conclusion, we have demonstrated that socioeconomic deprivation is associated with shorter 
survival after heart transplantation in England.  Socioeconomic deprivation of recipients should be 
evaluated as a potential risk factor in adjustment of survival data for performance monitoring of 
individual transplant centers.  More importantly, research is required to identify and develop strategies 
to address modifiable mediators of the association between SED and shorter survival, with a view to 
improving outcomes for more deprived patients undergoing heart transplantation. 
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Table 1. Characteristics of patients in the cohort  
Data presented for the cohort as a whole and for each SED quintile. Data presented as mean (SD), median [IQR] or count (%).  
 
 
Overall Quintile 1 
(most deprived) 
Quintile 2 Quintile 3 Quintile 4 Quintile 5 
(least deprived) 
p-value 
Number of patients 
 
2384 509 (21.3) 495 (20.8) 494 (20.7) 442 (18.5) 444 (18.6)  
Age (n=2384) 
 
51 [41-57] 49 [38-55] 49 [40-56] 51 [42-57] 51 [42-57] 52 [44-58] <0.001 
Sex (n=2384) 
   Male 
   Female 
 
1879 (78.8) 
505 (21.2) 
 
387 (76.0) 
122 (24.0) 
 
386 (77.0) 
109 (22.0) 
 
393 (79.6) 
101 (20.45) 
 
361 (81.7) 
81 (18.3) 
 
352 (79.3) 
92 (20.7) 
 
0.071 
 
Ethnicity (n=2314) 
   Caucasian 
   Black 
   South Asian 
   Other 
 
 
 
2110 (91.2) 
39 (1.7) 
138 (6.0) 
27 (1.2) 
 
 
424 (85.5) 
20 (4.0) 
43 (8.7) 
9 (1.8) 
 
 
430 (90.0) 
11 (2.3) 
32 (6.6) 
7 (1.4) 
 
 
442 (92.3) 
6 (1.3) 
30 (6.3) 
1 (0.2) 
 
 
406 (94.4) 
2 (0.5) 
13 (3) 
9 (2.1) 
 
 
408 (95.1) 
0 (0) 
20 (4.7) 
1 (0.2) 
 
 
<0.001 
BMI (n=2333) 
 
25.4 (4.0) 25.5 (4.1) 25.6 (4.0) 25.5 (3.9) 25.3 (4.2) 25.2 (3.8) 0.320 
Aetiology (n=2365) 
   Ischaemic heart disease 
   Cardiomyopathy 
   Congenital  
   Other 
 
718 (30.4) 
1293 (54.7) 
109 (4.6) 
245 (10.4) 
 
 
180 (35.7) 
258 (51.2) 
20 (4.0) 
46 (9.1) 
 
137 (27.9) 
272 (55.4) 
33 (6.7) 
49 (10.0) 
 
138 (28.2) 
272 (55.6) 
22 (4.5) 
57 (11.7) 
 
144 (32.9) 
240 (54.8) 
15 (3.4) 
39 (8.9) 
 
119 (26.9) 
251 (56.7) 
19 (4.3) 
54 (12.2) 
 
0.264 
Previous open heart surgery (n=2215) 
 
159 (7.2) 31 (8.7) 40 (8.7) 32 (7.0) 25 (6.0) 31 (7.6) 0.516 
Diabetes (n=2218) 
 
207 (9.3) 45 (9.5) 52 (11.4) 35 (7.6) 44 (10.6) 31 (7.5) 0.242 
In hospital pre-transplant (n=2326) 
 
847 (36.4) 185 (37.2) 179 (37.1) 165 (34.2) 149 (34.6) 169 (39.1) 0.450 
Serum creatinine (n=2124) 
 
112 [91-135] 103 [87-128] 113 [91-137] 110 [93-132] 116 [95-139] 115 [93-140] 0.015 
Ischaemic time (n=2125) 
   <120 minutes 
   120-179 
   180-239 
   >240 
 
 
196 (9.2) 
645 (30.4) 
819 (38.5) 
465 (21.9) 
 
31 (6.9) 
130 (29) 
183 (40.9) 
104 (23.2) 
 
43 (9.6) 
133 (29.7) 
180 (40.2) 
92 (20.5) 
 
35 (8.0) 
128 (29.2) 
173 (39.5) 
102 (23.3) 
 
43 (10.9) 
128 (32.5) 
143 (36.3) 
80 (20.3) 
 
44 (11.1) 
126 (31.7) 
140 (35.3) 
87 (21.9) 
 
0.106 
Ventilated at registration (n=1448) 
 
40 (2.8) 10 (3.1) 6 (2.0) 9 (3.0) 9 (3.5) 6 (2.2) 0.819 
Donor age (n=2384) 
 
37 [25-46] 36 [24-46] 35 [25-45] 
 
38 [25-47] 37 [25-47] 37 [27-45] 0.327 
Donor sex (n=2384) 
   Male 
   Female 
 
 
787 (33.0) 
1597 (67.0) 
 
158 (31.0) 
351 (69.0) 
 
170 (34.3) 
325 (65.7) 
 
173 (35.0) 
321 (65.0) 
 
142 (32.1) 
300 (67.9) 
 
144 (32.4) 
300 (67.6) 
 
0.449 
Donor diabetes (n=2076) 55 (2.7) 7 (1.6) 13 (3.1) 13 (2.9) 13 (3.3) 9 (2.3) 0.911 
 
Follow-up duration, years (n=2384) 
 
6.1 [1.0-12.1] 
 
5.9 [1.0-11.7] 
 
6.0 [1.0-12.0] 
 
6.9 [1.0-12.0] 
 
6.9 [1.0-13.0] 
 
6.0 [0.9-12.1] 
 
0.368 
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Table 2. Association between socioeconomic deprivation and 30-day mortality. 
Unadjusted and risk adjusted odds ratios (95% confidence interval) for 30-day mortality by SED 
quintile.  
 
SED Quintile Number of 
patients 
Deaths at 30 
days 
Unadjusted 
OR (95% CI) 
P-value Risk Adjusted* 
OR  (95% CI) 
P-value 
5 (least deprived) 444 50 (11.3%) 1.00 - 1.00 - 
4 442 58 (13.1%) 1.19 (0.80-1.78) 0.398 1.25 (0.82-1.89) 0.294 
3 494 55 (11.1%) 0.99 (0.66-1.48) 0.951 0.95 (0.62-1.45) 0.813 
2 495 61 (12.3%) 1.11 (0.74-1.65) 0.615 1.09 (0.72-1.65) 0.674 
1 (most deprived) 509 48 (9.4%) 0.82 (0.54-1.25) 0.354 0.83 (0.53-1.29) 0.403 
*Adjusted for age, sex, ethnicity, diabetes, heart disease aetiology (dilated cardiomyopathy, ischaemic 
heart disease, congenital heart disease, other), pre-transplant serum creatinine, previous cardiac 
surgery, inpatient or outpatient prior to transplantation, ventilation status at registration (ventilated/not 
ventilated), donor age and donor sex. 
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Table 3. Association between socioeconomic deprivation and one-year mortality. 
Unadjusted and risk adjusted hazard ratios (95% confidence interval) for death during the first year by 
SED quintile. One year mortality generated using unadjusted Kaplan Meier estimates. 
 
SED Quintile One-year mortality 
% (95% CI) 
 
Unadjusted 
HR (95% CI) 
P-value Risk Adjusted* 
HR  (95% CI) 
P-value 
5 (least deprived) 20.1 (16.6-24.2) % 1.00 - 1.00 - 
4 19.9 (16.5-24.0) % 1.03 (0.76-1.38) 0.870 1.04 (0.77-1.41) 0.779 
3 19.3 (16.0-23.1) % 0.98 (0.73-1.31) 0.883 0.90 (0.67-1.22) 0.503 
2 19.8 (16.5-23.6) % 1.00 (0.75-1.34) 0.989 0.99 (0.73-1.33) 0.941 
1 (most deprived) 18.2 (15.1-21.9) % 0.92 (0.68-1.25) 0.613 0.91 (0.66-1.24) 0.534 
*Adjusted for age, sex, ethnicity, diabetes, heart disease aetiology (dilated cardiomyopathy, ischaemic 
heart disease, congenital heart disease, other), pre-transplant serum creatinine, previous cardiac 
surgery, inpatient or outpatient prior to transplantation, ventilation status at registration (ventilated/not 
ventilated), donor age and donor sex. 
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Table 4. Association between socioeconomic deprivation and long-term survival. 
Unadjusted and risk-adjusted hazard ratios (95% confidence interval) by SED quintile and for IMD 
rank as a continuous variable per quintile increase (indicates increase in relative SED). 
 
Overall Survival 
SED Quintile Unadjusted HR 
(95% CI) 
P-value Risk-adjusted* 
HR (95% CI) 
P-value Median Survival 
(95% CI) 
5 (least deprived) 1.00 - 1.00 - 15.0 (13.2-17.1) 
4 1.11 (0.91-1.36) 0.295 1.14 (0.93-1.39) 0.217 14.1 (12.1-15.2) 
3 1.11 (0.91-1.35) 0.319 1.11 (0.91-1.35) 0.321 12.3 (11.2-13.9) 
2 1.24 (1.02-1.51) 0.030 1.27 (1.05-1.55) 0.016 11.3 (10.0-13.5) 
1 (most deprived) 1.22 (1.00-1.49) 0.047 1.27 (1.04-1.55) 0.021 11.6 (9.1-12.6) 
      
Per quintile increase 
in SED 
1.05 (1.00-1.09) 0.032 1.06 (1.01-1.10) 0.012 - 
 Conditional Survival  
SED Quintile Unadjusted HR 
(95% CI) 
P-value Risk-adjusted 
HR* (95% CI) 
P-value Median Survival 
(95% CI) 
5 (least deprived) 1.00 - 1.00 - 17.8 (15.4-20.3) 
4 1.21 (0.92-1.59) 0.174 1.24 (0.94-1.64) 0.124 15.8 (14.6-17.0) 
3 1.23 (0.94-1.62) 0.129 1.26 (0.96-1.65) 0.097 16.2 (13.4-19.0) 
2 1.48 (1.94-1.92) 0.004 1.55 (1.19-2.03) 0.001 14.8 (13.1-18.0) 
1 (most deprived) 1.51 (1.15-1.97) 0.003 1.59 (1.22-2.09) 0.001 14.4 (12.3-15.6) 
      
Per quintile increase 
in SED 
1.09 (1.03-1.15) 0.002 1.11 (1.05-1.17) <0.001 - 
*Adjusted for age, sex, ethnicity, diabetes, pre-transplant creatinine, heart failure aetiology, donor age 
and donor sex  
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Table 5. Association of Index of Multiple Deprivation domains with long-term survival.  
Risk-adjusted hazard ratios (95% confidence interval) per quintile increase in rank in each of the 7 
IMD domains. Increase in IMD rank indicates increase in relative SED. 
 
Overall Survival 
IMD Domain Risk-adjusted  
HR* (95% CI) 
P-value 
Income 1.06 (1.01-1.11) 0.011 
Employment 1.06 (1.01-1.11) 0.012 
Health 1.06 (1.01-1.11) 0.019 
Education 1.05 (1.01-1.09) 0.029 
Housing 0.99 (0.94-1.03) 0.554 
Crime 1.03 (0.99-1.07) 0.198 
Environment 1.06 (1.01-1.10) 0.015 
Conditional Survival 
IMD Domain Risk-adjusted  
HR* (95% CI)  
P-value 
Income 1.12 (1.06-1.18) <0.001 
Employment 1.11 (1.05-1.18) <0.001 
Health 1.12 (1.05-1.19) <0.001 
Education 1.11 (1.05-1.17) <0.001 
Housing 0.96 (0.91-1.02) 0.228 
Crime 1.06 (1.00-1.12) 0.037 
Environment 1.09 (1.03-1.15) 0.004 
*Adjusted for age, sex, ethnicity, diabetes, pre-transplant creatinine, heart failure aetiology, donor age 
and donor sex  
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Figure 1. Survival curves by socioeconomic deprivation quintile. 
Kaplan Meier survival curves comparing patients in the most deprived and least deprived quintiles. (A) 
Overall survival (p=0.008) and (B) Conditional survival (p<0.001). 
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Figure 2. Subgroup analysis 
Association of SED and A) Overall and B) conditional survival, by age at transplant, sex, ethnicity and 
heart failure aetiology. P-values presented for interaction between subgroups. 
 
